Pharmaceutical Lipids Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
The global pharmaceutical lipids market size was estimated to be US$ 4.3 billion in 2021 and is expected grow at a CAGR of 5.2% between 2023 to 2032.
Many prescription medications require lipids and lipid polymers during their manufacturing and thus are considered an important pharmaceutical excipient. They can work as solubilizers, transfection agents, activity enhancers, stabilizers, or perform various other functions within the formulations. They can also act as active pharmaceutical ingredients by themselves.
Lipids are one of the vital components of living beings and together with carbohydrates and proteins form one of the most abundant substances found within animal and plant cells. Lipids are rapidly absorbed by the body; they provide energy and are essential in the formation of the cell membrane and cell structure. They are also essential in the production of hormones (cortisols and steroids), waxes, and other neutral fats by the organism. Lipids can also form complex biological molecules with other organic and inorganic compounds. The two most important types of lipids are called triglycerides and cholesterols which are also extensively used in the pharmaceutical industries.
Uses of pharmaceutical lipid products:
Semi-synthetic, synthetic, or natural lipid monomers and polymers are increasingly used during the production of various pharmaceutical formulations. Lipids are also used in the formulation of mRNA therapeutic medications. Furthermore, lipid nanoparticle-based delivery systems are safe and helpful for several treatments including covid-19. These features of lipids enable their use in pharmaceutical formulations and substitutes which has enabled the global pharmaceutical lipids market to grow along with the overall pharmaceutical industry in recent years.
Conditions such as neurological disorders, cancer, cardiovascular diseases, and other organ disorders have seen an increased use of lipids in drug formulations. Due to the increase in the prevalence of such disorders the growth of pharmaceutical lipids market is anticipated to grow substantially. The Discovery of novel treatments against such diseases will also require specialized drug delivery systems which are also expected to increase the growth of this market in coming years.
Growth factors:
The worldwide healthcare sector is also undergoing rapid research and development. The development of new formulations and drugs along with their delivery systems is going to provide a significant role in pharmaceutical lipids which will increase their demand. Diagnosis and detection of new diseases have propelled the R&D initiatives which are expecting to have drugs-based treatments ready within the coming decade. These factors are playing an important role in increased demand and expected growth of the pharmaceutical lipids market during the forecast period.
New lipid-based formulations that have a better degree of emulsification, higher dispersion potential, and increased particle magnitude are deemed to propel the growth of this market substantially. Additionally, the requirement of lipids for the treatment of chronic conditions such as cystic fibrosis, cancer, asthma, arthritis, and diabetes will further increase the demand for pharmaceutical lipid products as the cases of such diseases are expected to rise within the study period.
The rise of innovative biotechnological and pharmaceutical products across the globe has increased the regulatory processes that are involved in drug formulations. The legal requirements of a country's drug discovery process are addressed effectively by such regulatory bodies and organizations.
These regulatory organizations are in charge of monitoring compliance, enforcing rules and regulations, and creating standards to regulate the production, licensing, marketing, registration, and labelling of pharmaceutical products. Several lipid compounds have been used in drug formulation for a very long and their track record is also reliable. Due to this, they are widely supported in drug formulations by these regulatory agencies.
Thus, the global pharmaceutical lipids market is expected to have no impact in the long term due to stringent regulatory measures. However, drug formulations with new lipid compounds or complex admixtures may see legal hurdles and their growth may be impacted.
The past several years have seen increased third-party outsourcing activity for lipid production by major pharmaceutical corporations. This allows pharmaceutical companies to take advantage of evolving technology, gain access to greater capacities, and enhance flexibility and adaptability while developing their drugs and products. Several medical-grade lipid products like lipid nanoparticles, liposomes, and other lipid excipients are now manufactured by large well established third-party manufacturers. Due to this reason the pharmaceutical lipids market has achieved an economically feasible and strategically stable position which is further expected to strengthen during the forecast period.
Regional distribution and growth forecast:
The pharmaceutical lipids market is regionally divided into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. Due to considerable government funding for pharmaceutical research, the industry in North America is anticipated to contribute a significant revenue share in the worldwide pharmaceutical lipids market.
Throughout the projected period, it is expected that the Asia-Pacific region's market will grow the fastest. The favorable influences of China and India on the regional pharmaceutical industry and their legislative policies are favorable to the pharmaceutical industry and are attributed to the expected growth of the pharmaceutical lipids market in this region. The market is also being influenced by a booming population, lifestyle changes, and a significant increase in disposable income.
The Asia-Pacific region is also anticipated to have rapid growth during the anticipated period because of the increasing demand for nutraceutical therapies. Because of the rising need for lipids in the nutraceutical industry. India is expected to play a leading role in the growth of the Asia-Pacific pharmaceutical lipids market.
Key player and strategies in pharmaceutical lipids market:
Some of the prominent companies in the pharmaceutical lipids market are ABITEC Corporation, BASF SE, Cayman Chemical Company, Croda International Plc, Corden Pharma, Dishman Group, Evonik Industries AG., Gattefossé, IOI Oleo GmbH, Lipoid GmbH, Merck KGaA, Nippon Oil & Fats Corporation, Nippon Fine Chemical Co. Ltd., and Stepan Company.
All the major vendors in the global pharmaceutical lipids market are primarily focused on scaling up their production activity. Other efforts like increasing product quality, diversifying the product portfolio, increasing acquisition, and collaborations are also expected to create a surge in the pharmaceutical lipids market within the coming years.
Market Segmentation:
By Product
- Triglycerides
- Phospholipids
- Sphingolipids
- Cholesterol
- Fatty Acids
- Others
By Source
- Synthetic
- Semi-synthetic
- Natural
By Form
- Liquid
- Semi-solid
- Solid
By Application
- Conventional Lipid-based Drug Delivery Systems
- Self-Emulsifying Drug Delivery Systems
- Self-Microemulsifying Drug Delivery Systems
- Liposomes
- Solid Lipid Nanoparticles
- Nanostructured Lipid Carriers
- Others
By Route of Administration
- Oral
- Tablet
- Solution
- Parenteral
- Intravenous
- Intramuscular (Vaccines)
- Topical
By Geography
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- South America
- Brazil
- Rest of South America
- Introduction
- Research Objectives
- Report Assumptions
- Research Methodology
- Abbreviations
- Preface
- Market Definition
- Report Scope and Market Segmentation
- Research Highlights
- Market Synopsis: Global Pharmaceutical Lipids Market
- Global Pharmaceutical Lipids Market Qualitative Analysis
- Trends
- Market trends
- Technology Trends
- PESTLE Analysis (For 3 prominent countries)
- Market Influencers
- Driving Forces
- Hindering Forces
- Opportunities
- COVID-19 impact
- Porter’s Five Forces Analysis
- Value Chain Analysis
- Trends
- Global Pharmaceutical Lipids Market Analysis and Forecast, by Product
- Overview and definitions
- Key segment analysis
- Global Pharmaceutical Lipids Market Estimates (US$ Mn), Product, 2019 – 2032
- Triglycerides
- Phospholipids
- Sphingolipids
- Cholesterol
- Fatty Acids
- Others
- Global Pharmaceutical Lipids Market Analysis and Forecast, by Source
- Overview and definitions
- Key segment analysis
- Global Pharmaceutical Lipids Market Estimates (US$ Mn), Source, 2019 – 2032
- Synthetic
- Semi-synthetic
- Natural
- Global Pharmaceutical Lipids Market Analysis and Forecast, by Form
- Overview and definitions
- Key segment analysis
- Global Pharmaceutical Lipids Market Estimates (US$ Mn), Form, 2019 – 2032
- Liquid
- Semi-solid
- Solid
- Global Pharmaceutical Lipids Market Analysis and Forecast, by Route of Administration
- Overview and definitions
- Key segment analysis
- Global Pharmaceutical Lipids Market Estimates (US$ Mn), Route of Administration, 2019 – 2032
- Oral
- Tablet
- Solution
- Parenteral
- Intravenous
- Intramuscular (Vaccines)
- Topical
- Oral
- Global Pharmaceutical Lipids Market Analysis and Forecast, by Application
- Overview and definitions
- Key segment analysis
- Global Pharmaceutical Lipids Market Estimates (US$ Mn), Application, 2019 – 2032
- Conventional Lipid-based Drug Delivery Systems
- Self-Emulsifying Drug Delivery Systems
- Self-Microemulsifying Drug Delivery Systems
- Liposomes
- Solid Lipid Nanoparticles
- Nanostructured Lipid Carriers
- Others
- Global Pharmaceutical Lipids Market Analysis and Forecast, by Region
- Overview and definitions
- Key segment analysis
- Global Pharmaceutical Lipids Market Estimates (US$ Mn), by Region, 2019 – 2032
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
- North America Pharmaceutical Lipids Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- North America Pharmaceutical Lipids Market Estimates (US$ Mn), Product, 2019 – 2032
- Triglycerides
- Phospholipids
- Sphingolipids
- Cholesterol
- Fatty Acids
- Others
- North America Pharmaceutical Lipids Market Estimates (US$ Mn), Source, 2019 – 2032
- Synthetic
- Semi-synthetic
- Natural
- North America Pharmaceutical Lipids Market Estimates (US$ Mn), Form, 2019 – 2032
- Liquid
- Semi-solid
- Solid
- North America Pharmaceutical Lipids Market Estimates (US$ Mn), Route of Administration, 2019 – 2032
- Oral
- Tablet
- Solution
- Parenteral
- Intravenous
- Intramuscular (Vaccines)
- Topical
- Oral
- North America Pharmaceutical Lipids Market Estimates (US$ Mn), Application, 2019 – 2032
- Conventional Lipid-based Drug Delivery Systems
- Self-Emulsifying Drug Delivery Systems
- Self-Microemulsifying Drug Delivery Systems
- Liposomes
- Solid Lipid Nanoparticles
- Nanostructured Lipid Carriers
- Others
- North America Pharmaceutical Lipids Market Estimates (US$ Mn), by Country, 2019 – 2032
- United States
- Canada
- Rest of North America
- Europe Pharmaceutical Lipids Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Europe Pharmaceutical Lipids Market Estimates (US$ Mn), Product, 2019 – 2032
- Triglycerides
- Phospholipids
- Sphingolipids
- Cholesterol
- Fatty Acids
- Others
- Europe Pharmaceutical Lipids Market Estimates (US$ Mn), Source, 2019 – 2032
- Synthetic
- Semi-synthetic
- Natural
- Europe Pharmaceutical Lipids Market Estimates (US$ Mn), Form, 2019 – 2032
- Liquid
- Semi-solid
- Solid
- Europe Pharmaceutical Lipids Market Estimates (US$ Mn), Route of Administration, 2019 – 2032
- Oral
- Tablet
- Solution
- Parenteral
- Intravenous
- Intramuscular (Vaccines)
- Topical
- Oral
- Europe Pharmaceutical Lipids Market Estimates (US$ Mn), Application, 2019 – 2032
- Conventional Lipid-based Drug Delivery Systems
- Self-Emulsifying Drug Delivery Systems
- Self-Microemulsifying Drug Delivery Systems
- Liposomes
- Solid Lipid Nanoparticles
- Nanostructured Lipid Carriers
- Others
- Europe Pharmaceutical Lipids Market Estimates (US$ Mn), by Country, 2019 – 2032
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific Pharmaceutical Lipids Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Asia Pacific Pharmaceutical Lipids Market Estimates (US$ Mn), Product, 2019 – 2032
- Triglycerides
- Phospholipids
- Sphingolipids
- Cholesterol
- Fatty Acids
- Others
- Asia Pacific Pharmaceutical Lipids Market Estimates (US$ Mn), Source, 2019 – 2032
- Synthetic
- Semi-synthetic
- Natural
- Asia Pacific Pharmaceutical Lipids Market Estimates (US$ Mn), Form, 2019 – 2032
- Liquid
- Semi-solid
- Solid
- Asia Pacific Pharmaceutical Lipids Market Estimates (US$ Mn), Route of Administration, 2019 – 2032
- Oral
- Tablet
- Solution
- Parenteral
- Intravenous
- Intramuscular (Vaccines)
- Topical
- Oral
- Asia Pacific Pharmaceutical Lipids Market Estimates (US$ Mn), Application, 2019 – 2032
- Conventional Lipid-based Drug Delivery Systems
- Self-Emulsifying Drug Delivery Systems
- Self-Microemulsifying Drug Delivery Systems
- Liposomes
- Solid Lipid Nanoparticles
- Nanostructured Lipid Carriers
- Others
- Asia Pacific Pharmaceutical Lipids Market Estimates (US$ Mn), by Country, 2019 – 2032
- China
- Japan
- South Korea
- India
- Australia
- Rest of Asia Pacific
- Middle East & Africa Pharmaceutical Lipids Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Middle East & Africa Pharmaceutical Lipids Market Estimates (US$ Mn), Product, 2019 – 2032
- Triglycerides
- Phospholipids
- Sphingolipids
- Cholesterol
- Fatty Acids
- Others
- Middle East & Africa Pharmaceutical Lipids Market Estimates (US$ Mn), Source, 2019 – 2032
- Synthetic
- Semi-synthetic
- Natural
- Middle East & Africa Pharmaceutical Lipids Market Estimates (US$ Mn), Form, 2019 – 2032
- Liquid
- Semi-solid
- Solid
- Middle East & Africa Pharmaceutical Lipids Market Estimates (US$ Mn), Route of Administration, 2019 – 2032
- Oral
- Tablet
- Solution
- Parenteral
- Intravenous
- Intramuscular (Vaccines)
- Topical
- Oral
- Middle East & Africa Pharmaceutical Lipids Market Estimates (US$ Mn), Application, 2019 – 2032
- Conventional Lipid-based Drug Delivery Systems
- Self-Emulsifying Drug Delivery Systems
- Self-Microemulsifying Drug Delivery Systems
- Liposomes
- Solid Lipid Nanoparticles
- Nanostructured Lipid Carriers
- Others
- Middle East & Africa Pharmaceutical Lipids Market Estimates (US$ Mn), by Country, 2019 – 2032
- UAE
- Saudi Arabia
- South Africa
- Rest of MEA
- South America Pharmaceutical Lipids Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- South America Pharmaceutical Lipids Market Estimates (US$ Mn), Product, 2019 – 2032
- Triglycerides
- Phospholipids
- Sphingolipids
- Cholesterol
- Fatty Acids
- Others
- South America Pharmaceutical Lipids Market Estimates (US$ Mn), Source, 2019 – 2032
- Synthetic
- Semi-synthetic
- Natural
- South America Pharmaceutical Lipids Market Estimates (US$ Mn), Form, 2019 – 2032
- Liquid
- Semi-solid
- Solid
- South America Pharmaceutical Lipids Market Estimates (US$ Mn), Route of Administration, 2019 – 2032
- Oral
- Tablet
- Solution
- Parenteral
- Intravenous
- Intramuscular (Vaccines)
- Topical
- Oral
- South America Pharmaceutical Lipids Market Estimates (US$ Mn), Application, 2019 – 2032
- Conventional Lipid-based Drug Delivery Systems
- Self-Emulsifying Drug Delivery Systems
- Self-Microemulsifying Drug Delivery Systems
- Liposomes
- Solid Lipid Nanoparticles
- Nanostructured Lipid Carriers
- Others
- South America Pharmaceutical Lipids Market Estimates (US$ Mn), by Country, 2019 – 2032
- Brazil
- Argentina
- Rest of South America
- Competition Analysis – Global Pharmaceutical Lipids Market
- Market Composition
- Market Share Analysis (%), by Supplier (2022)
- Company Profiles
- ABITEC Corporation
- Business overview
- Geographic presence
- Product portfolio
- Financial facts
- Relevant news and strategic view
- BASF SE
- Cayman Chemical Company
- Croda International Plc
- Corden Pharma
- Dishman Group
- Evonik Industries AG.
- Gattefossé
- IOI Oleo GmbH
- Lipoid GmbH
- Merck KGaA
- Nippon Oil & Fats Corporation
- Nippon Fine Chemical Co. Ltd.
- Stepan Company
- ABITEC Corporation
- Conclusion & Recommendations
Frequently asked questions about this report
What are the uses of lipid substances in pharmaceutical industry?
Semi-synthetic, synthetic, or natural lipid monomers and polymers are used in various pharmaceutical formulations and also in mRNA therapeutic medications.
What regions are covered in the global pharmaceutical lipids report?
We have segmented the Global pharmaceutical lipids by geography in North America, Europe, Asia, ROW, and MEA regions with breakdown of factors affecting growth in every region.
What is the estimated growth rate of the global pharmaceutical lipids market from 2023 to 2032?
The global pharmaceutical lipids market is estimated to expand at a CAGR of 5.2% between 2023 to 2032.
What was the market for pharmaceutical lipids valued at in 2021?
The pharmaceutical lipids market size was estimated to be US$ 4.3 billion in 2021
How is the regional performance of the market?
The Asia-Pacific region is also anticipated to have rapid growth during the anticipated period because of the increasing demand for nutraceutical therapies. Because of the rising need for lipids in the nutraceutical industry. India is expected to play a leading role in the growth of the Asia-Pacific pharmaceutical lipids market.
Who are the top players in the global pharmaceutical lipids?
ABITEC Corporation, BASF SE, Cayman Chemical Company, Croda International Plc, Corden Pharma, Dishman Group, Evonik Industries AG, Gattefossé, IOI Oleo GmbH, Lipoid GmbH, Merck KGaA, Nippon Oil & Fats Corporation, Nippon Fine Chemical Co. Ltd., and Stepan Company are a few of the well-known businesses in the pharmaceutical lipids market.